What changed in this filing

/stocks — the workspaceLOADING

Item 7. Management’s Discussion and Analysis

2026-03-04 compared with 2025-02-26 · 213 added, 334 removed, 431 unchanged (56% of the section changed)

9 unchanged sentences

in a 53-week fiscal year, each of the first, second and third quarters includes 13 weeks of operations and the fourth quarter includes 14 weeks of operations.

References herein to “fiscal year 2024” relate to

the 52 weeks ended December 28, 2024, references herein to “fiscal year 2023” relate to the 52 weeks ended December 30, 2023 and references herein to “fiscal year 2022” relate to the 52 weeks ended December 31, 2022.

References herein to “fiscal year 2025” relate to the 53 weeks ended January 3, 2026, references

herein to “fiscal year 2024” relate to the 52 weeks ended December 28, 2024 and references herein to “fiscal year 2023” relate to the 52 weeks ended December 30, 2023.

The disclosures contained in this Form 10-K are made only as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as required by law.

For further information, please see “Risk Factors” and “Forward-Looking Statements.”

We are one of the largest optical retailers in the United States (the “U.S.”) and a leader in the attractive value segment of the U.S.

We are one of the largest optical retailers in the United States (“U.S.”) and a leader in the value segment of the U.S.

optical retail industry.

We believe that vision is central to quality of life and that people deserve to see their best to live their best, regardless of their budget.

We achieve this by providing eye exams, eyeglasses and contact lenses to value-seeking consumers with an opening price point that strives to be among the lowest in the industry.

We reach our customers through a diverse portfolio of 1,240 retail stores across four brands and multiple consumer websites as of fiscal year end 2024.

We believe that vision is central to quality of life and that people deserve to see their best to live their best.

Our mission is to help people by making quality eye care and eyewear more affordable and accessible.

We achieve this by providing eye exams, eyeglasses and contact lenses to consumers across the nation.

Our range of quality product offerings at multiple price points makes us an attractive destination for consumers of all income levels.

As of January 3, 2026, our 2025 fiscal year end, we reach our customers through a diverse portfolio of 1,250 retail stores across four brands, our associated omni-channel consumer websites, and our dedicated e-commerce consumer website.

Brand and Segment Information

As of December 28, 2024, our operations consisted of one reportable segment:

• Owned & Host – As of fiscal ye ar end 2024, our owned brands consist ed of 1,036 America’s Best Contacts and Eyeglasses (“America’s Best”) retail stores and 122 Eyeglass World retail stores.

In America’s Best stores, vision care services are provided by optometrists employed by u s or by independent professional corporations or similar entities.

As of January 3, 2026, our operations consisted of one reportable segment.

During fiscal year 2024, our Walmart store operations, including our former Legacy reportable segment (“Legacy”) and components of our AC Lens operating segment met the requirements to be classified as discontinued operations.

• Owned & Host – As of fiscal ye ar end 2025 , our owned brands consisted of 1,057 America’s Best Contacts and Eyeglasses (“America’s Best”) retail stores and 122 Eyeglass World retail stores.

In America’s Best stores, vision care services are provided by optometrists employed by us or by independent professional corporations or similar entities.

America’s Best stores are primarily located in high-traffic strip centers next to value-focused retailers.

Eyeglass World locations offer eye exams, provided primarily by independent optometrists and optometrists employed by independent professional corporations or similar entities, and have on-site optical laboratories that enable stores to quickly fulfill many customer orders and make repairs on site.

Eyeglass World locations offer eye exams, provided by optometrists employed either by us or independent professional corporations or similar entities, and have on-site optical laboratories that enable stores to quickly fulfill many customer orders and make repairs on site.

Eyeglass World stores are primarily located in freestanding or in-line locations near high-foot-traffic shopping centers.

5 unchanged sentences

Our consolidated results for all periods presented in this Form 10-K also include the following:

• Results of other operating segments — Our dedicated e-commerce website, which was previously managed by AC Lens and was transitioned to NVI.

Our e-commerce website sells contact lenses and optical accessory products to retail customers, and recognizes revenue when products have been delivered to the customer.

Managed care business conducted by FirstSight, our wholly-owned subsidiary that is licensed as a single-service health plan under California law, which issues individual vision plans in connection with our America’s Best operations in California.

• Corporate and other — Our corporate and other category represents unallocated corporate overhead expenses, which are a component of selling, general and administrative expenses and are comprised of various home office expenses such as payroll, occupancy costs and consulting and professional fees.

• Corporate and other — Our corporate and other category includes the results of our dedicated e-commerce website, which sells contact lenses and optical accessory products to retail customers, and recognizes revenue when products have been delivered to the customer and our managed care business conducted by FirstSight, our wholly-owned subsidiary that is licensed as a single-service health plan under California law, which issues individual vision plans in connection with our America’s Best operations in California.

Our “corporate and other” category also includes unallocated corporate overhead expenses, which are a component of Selling, general and administrative expenses (“SG&A”) and are comprised of various home office expenses such as payroll, occupancy costs and consulting and professional fees.

Corporate overhead expenses also include field services for our four retail brands.

Other expenses included in this category include certain non-cash charges, including asset impairment, stock-based compensation expense, and the impact of certain events, gains, or losses excluded from the assessment of segment performance.

• Effects of unearned and deferred revenue — Reportable segment information is presented on the same basis as our consolidated financial statements, except reportable segment sales which are presented on a cash basis, including point of sales for managed care payors and excluding the effects of unearned and deferred revenue, consistent with what our chief operating decision maker (“CODM”) regularly reviews.

• Effects of unearned and deferred revenue — Reportable segment information is presented on the same basis as our consolidated financial statements, except reportable segment revenues and associated costs applicable to revenue which exclude the effects of unearned and deferred revenue, consistent with what our chief operating decision maker (“CODM”) regularly reviews.

We present the effects of unearned and deferred revenues separately from our reportable segment information.

“Segment Reporting” in our consolidated financial statements.

Deferred revenue represents the timing difference of when we collect the cash from the customer and when services related to product protection plans and eye care club memberships are performed.

Deferred revenue represents the timing difference between the point of sale and when services related to product protection plans and eye care club memberships are performed.

Increases or decreases in deferred revenue during the reporting period represent cash collections in excess of, or below the recognition of, previous deferrals.

Unearned revenue represents the timing difference of when we collect cash from the customer and delivery/customer acceptance, and includes sales of prescription eyewear during approximately the last seven to ten days of the reporting period.

Unearned revenue represents the timing difference between the point of sale transaction and delivery/customer acceptance, and includes sales of prescription eyewear during approximately the last two weeks of the reporting period.

Trends and Other Factors Affecting Our Business

During fiscal 2024, we implemented transformation initiatives intended to accelerate long-term growth and strengthen profitability, including new additions to our executive leadership team, continued expansion of exam capacity, new traffic-driving initiatives, and a review of our store fleet.

Additionally, we continued to make progress against our continued growth initiatives, including the expansion of our remote medicine capabilities;

focusing on the recruiting and retention of optometrists;

increasing our marketing efficiency and omnichannel capabilities;

increasing our participation in vision insurance programs;

and the further digitization of our stores and corporate office.

Going into fiscal 2025, we will be focused on expanding our target demographic, implementing new pricing architecture, enhancing the customer and patient experience, and optimizing cost structure, which are designed to strengthen our core business, improve our results of operations, and drive long-term shareholder value.

We opened 69 new stores in 2024 and completed a comprehensive review of our portfolio of stores to optimize our fleet for profitability and overall performance.

As a result of the comprehensive review, we closed 12 stores and converted four Eyeglass World stores to America’s Best stores in 2024 and plan to close an additional 27 stores by the end of 2026.

In connection with this review, we have recorded certain impairment of intangible assets, property and equipment and ROU assets, as well as one-time non-recurring exit charges associated with the closures.

Refer to Note 1.

“Description of Business and Basis of Presentation” and Note 11.

“Fair Value Measurement” for information on the impairment charges and costs incurred related to the store fleet review.

We are continuing to invest in the digitization of our stores, including remote medicine capabilities and an EHR platform.

As of December 28, 2024, remote medicine technology has been enabled in over 730 of our America’s Best locations.

We believe remote medicine not only helps provide more access to eye care for patients, it also helps address constraints in exam capacity.

We have also invested in the transition to an EHR platform.

We anticipate continuing the investment in remote medicine primarily in America’s Best stores in the near term, adding select locations where feasible and advantageous and depending on the state-by-state regulatory environment.

While the remote medicine and EHR platforms have increased exam capacity, revenue and profitability, we have experienced higher costs applicable to revenue as a percentage of revenue, when compared with in-store exams.

Historically, our business model primarily targeted lower-income consumers with a go-to-market strategy focused on merchandise and messaging of the lowest price.

We evolved our operating model in light of the impact of Covid to address changing consumer and doctor preferences, including by introducing cutting edge remote telehealth capabilities, which are now installed in over 800 of our locations.

We believe this differentiator greatly improves our ability to provide consistent access to patient care across our network of stores.

In fiscal 2024, we began implementing transformation initiatives designed to accelerate long-term growth and strengthen profitability, including new additions to our executive leadership team, continued expansion of exam capacity, new traffic-driving initiatives.

In 2025, we embarked on the next phase of our transformation, focused on the rapid modernization of our business in the context of contemporary consumer needs and wants.

Our strategy is focused around creating a more joyful consumer experience with refreshed merchandising, updated marketing and brand assets, new in-store technologies to support the customer journey, and an updated pricing architecture, all of which allow us to better serve our existing customers and expand our target consumer demographics.

During 2025, as an embodiment of our transformation, we refreshed the National Vision and America’s Best brand identities.

We also introduced a new America’s Best brand promise, “Every Eye Deserves Better,” which better reflects our customer mix.

These consumer-facing strategies are paired with an increased focus on cost optimization and operating margin expansion, all of which are intended to drive the outcome of a stronger core business and improved operating results.

The overall economic environment continues to be challenging and macroeconomic factors that may affect customer spending patterns, and thereby our results of operations, include inflation, employment rates, business conditions, changes in the housing market, the availability of credit, interest rates, tax rates and policies, fuel and energy costs and overall consumer confidence in future economic conditions, as well as g lobal political, socio-economic, cultural, and geopolitical uncertainty .

T he effects of the current macroeconomic environment and geopolitical uncertainty, resulted in reduced customer demand in 2025 and have caused shifts in consumer behaviors and preferences, which impact the demand for our products.

As a result, the predictability of recurring purchase behavior for the future remains uncertain, primarily for the cash pay consumer.

We operate in the highly competitive and fragmented U.S.

4 unchanged sentences

Our ability to continue to attract and retain qualified vision care professionals impacts exam capacity and our operations, like those of many of our competitors, depend on our ability to offer both eyewear and eye exams.

We believe factors such as an increasingly challenging recruiting market (in particular for new graduates), preferences for adjusted work schedules, and the demand for optometrists exceeding supply in certain areas during fiscal year 2024 have caused constraints in vision care professional availability and therefore exam capacity which are continuing.

We believe factors such as an increasingly challenging recruiting market (in particular for new graduates), preferences for adjusted work schedules, and the demand for optometrists exceeding supply in certain areas caused constraints in vision care professional availability and therefore exam capacity in recent years, which may continue.

As a result, recruiting and retaining optometrists has become more challenging and the costs to employee or retain optometrists have increased and may increase further, potentially materially.

Targeted wage investments, including increases in compensation for our optometrists and associates, and flexibility initiatives have impacted our costs applicable to revenue and selling, general and administrative expenses.

We anticipate that wage pressures in certain markets will continue in 2025.

Targeted wage investments, including increases in compensation for our optometrists and associates, and flexibility initiatives have impacted our costs applicable to revenue and SG&A expenses.

We anticipate that wage pressures in certain markets may continue to some degree in 2026.

Wage investment pressure and increases to costs applicable to revenue from increases in raw materials prices may not be able to be fully offset by leverage from revenue growth, productivity efficiency and, as appropriate, various pricing actions.

We are continuing to strategically invest in recruitment and retention initiatives, including flexible adjusted work schedules, along with continuing our implementation of remote medicine technologies, which has expanded our offerings while also increasing costs.

While there are ranges of customer behaviors based on demographics and other factors, we estimate that our customers typically replace their eyeglasses every two to three years and their contact lenses every six to 12 months, reflecting the predictability of these recurring purchase behaviors;

however, the effects of the current macroeconomic environment and geopolitical uncertainty, resulted in reduced customer demand in 2024 and have

caused shifts in consumer behaviors and preferences, which impact the demand for our products.

As a result, the predictability of recurring purchase behavior for the future remains uncertain.

We believe remote medicine not only helps provide more access to eye care for patients, it also helps address constraints in exam capacity.

In addition to the central factors impacting our business outlined above, we have identified the following key drivers, challenges and risks on which we are focused and which are detailed below.

9 unchanged sentences

The performance of new stores is dependent upon factors such as the availability of optometrists, implementation and operation of remote medicine technology, the time of year of a particular opening, the amount of store pre-opening costs, labor and occupancy costs in the specified market, level of participation in managed care plans, and location, including whether they are in new or existing markets.

During fiscal 2024, we announced plans to temporarily moderate new store openings in 2025 to 30-35 new stores, after which time we expect to return to our more recent store opening cadence as strategic initiatives begin to take hold.

During fiscal 2025, we opened 33 new stores, and we plan to open approximately 30 to 35 new stores in 2026, primarily comprised of America’s Best stores, after which time we expect to return to our more recent store opening cadence as strategic initiatives begin to take hold.

Comparable Store Sales Growth

1 unchanged sentence

Many factors affect comparable store sales, including:

• consumer confidence, preferences and buying trends and overall economic trends including inflation and the amount and timing of tax refunds;

• consumer confidence, preferences and buying trends and overall economic trends including inflation;

• the availability of optometrists and other vision care professionals;

20 unchanged sentences

An increasing percentage of our customers receive vision care insurance coverage through managed care payors.

Our participation in these programs represent an increasingly significant portion of our overall revenues and represented appro ximately 40% and 37% of our overall revenues from continuing operations in fiscal years 2024 and 2023, respectively .

Our participation in these programs represent an increasingly significant portion of our overall revenues and represen ted 42% of our overall revenues from continuing operations in fiscal 2025 .

While we have relationships with almost all vision care insurers in the U.S.

and with all of the major carriers, currently, a relatively small number of payors comprise the majority of our managed care revenues, subjecting us to concentration risk.

our participation in managed care programs continues to expand, we have incurred and expect to incur additional costs related to this area of our business.

Our comparable store sales growth as noted above as well as overall future operational success could depend on our ability to negotiate, maintain and extend contracts with managed vision care companies, vision insurance providers and other third-party payors, several of whom have significant market share.

As our participation in managed care programs continues to expand, we have incurred and expect to incur additional costs related to this area of our business.

Our comparable store sales growth as noted

above as well as overall future operational success could depend on our ability to negotiate, maintain and extend contracts with managed vision care companies, vision insurance providers and other third-party payors, several of whom have significant market share.

Coverage and payment levels are determined at each third-party payor’s discretion, and we have limited control over a third-party payor’s decision-making with respect to coverage and payment levels.

1 unchanged sentence

In addition, as our participation in managed care programs continues to approach overall industry penetration levels, we expect our associated managed care revenue growth rate to slow over time.

Through our point-of-sale system and our back-office electronic data interchange (“EDI”) capabilities, we attempt to create a seamless transactional experience for our managed care customers and we have increased training for our store associates with this goal in mind.

From time to time, vision care insurance payors may make changes to their benefit designs or claim systems, or experience system outages.

Such changes or outages may require us to update our processes and could impact our ability to submit claims or timely receive reimbursements from our managed care partners.

As such, we have worked proactively with our larger vision care insurance payors to implement technology to improve eligibility and benefit verification processes via application programming interfaces (“APIs”).

We have implemented such APIs with some of our largest payors and have seen improvements in the customer experience and reductions in claim errors that would otherwise result in rejections and potential write-offs.

Infrastructure Investment

Our historical results of operations reflect the impact of our ongoing investments in infrastructure to support our growth.

We have made and continue to make significant investments in information technology systems, including those to support our point-of-sale system, ERP, CRM, e-commerce platforms, supply chain systems, marketing, and personnel, as well as experienced industry executives, and management and merchandising teams to support our long-term growth objectives.

We have made and continue to make significant investments in information technology systems, including those to support our point-of-sale system, ERP, CRM, e-com merce platforms, supply chain systems, marketing, and personnel, as well as experienced industry executives, and management and merchandising teams to support our long-term growth objectives.

We intend to continue to make targeted investments in our infrastructure to support our growth and continue the digitization of our stores and corporate office.

Pricing Strategy

We are committed to providing our products to our customers at low prices.

We have historically employed a simple, low price/high value strategy and seek to balance our pricing and growth in a way that consistently delivers savings to our customers.

Inflationary pressures, including elevated wages, consumer confidence and preferences and increased raw material costs, could impact our profitability and lead us to att empt to offset such increases through various pricing actions.

From time to time, and increasingly in connection with our new transformation initiatives, we have taken and may continue to take pricing actions and introduce limited-time promotions or new offers designed to increase demand traffic, awareness and drive sales.

Effective January 26, 2025, we implemented a $10 price increase to each of our America’s Best signature offer and our Eyeglass World opening offer.

We are committed to providing our products to our customers at exceptional value.

We have historically employed a simple, low price/high value strategy, seeking to balance our pricing and growth in a way that consistently delivers savings to our customers.

We are continuing this commitment to value, while at the same modernizing our pricing strategy to maximize that value across a broader range of consumers.

We have taken and may continue to take pricing actions and introduce limited-time promotions or new offers designed to increase demand traffic, awareness and drive sales.

I n fiscal 2025, we implemented price increases to each of our America’s Best and Eyeglass World opening offers and continued to evolve our product mix to include a greater percentage of frames at price points over $99.

We believe that these changes will enable us to continue to offer the best possible value and service to our customers at prices that allow us to maintain our brands’ strong value propositions in the marketplace.

Interim Results and Seasonality

Historically, our business has realized a higher portion of net revenue, operating income, and cash flows from operations in the first half of the fiscal y ear, and a lower portion of net revenue, operating income, and cash flows from operations in the fourth fiscal quarter.

The first half seasonality is attributable primarily to the timing of our customers’ income tax refunds and annual health insurance program start/reset periods.

We believe that many customers in our target market of value-seeking consumers may rely on tax refunds to pay for eyewear and eye care.

A delay in the issuance of tax refunds or changes in the amount of tax refunds can accordingly have a negative impact on our quarterly financial results in the first half of the year.

Consumer behavior with respect to the utilization of tax refund proceeds is also subject to change.

The first half seasonality is attributable primarily to annual health insurance program start/reset periods and predictable consumer propensity to seek eye care and eyewear.

With respect to our fourth quarter results, compared to other retailers, our products and services are less likely to be included in consumers’ holiday spending budgets, therefore reducing spending on personal vision correction during the weeks preceding December 25th of each year.

Additionally, although the period between December 25th and the end of our fiscal year is typically a high-volume period, the net revenue associated with substantially all orders of prescription eyeglasses and contact lenses during that period is deferred until the following fiscal period due to our policy of recognizing revenue only after the product has been accepted by the customer, further contributing to higher revenue results in the first half of the year.

Additionally, although the period between December 25th and the end of our fiscal year is typically a high-volume period, the net revenue associated with a significant portion of orders of prescription eyeglasses and contact lenses during that period is deferred until the following fiscal period due to our policy of recognizing revenue only after the product has been accepted by the customer, further contributing to higher revenue results in the first half of the year.

Our quarterly results may also be affected by the timing of new store openings and store closings, the amount of sales contributed by new and existing stores, the timing of certain holidays, and the timing of weather-related store closures.

For both fiscal years 2024 and 2023, approximately 24% of our revenue was recorded in the fourth quarter, but approximately 25% of annual SG&A costs were recorded in the respective fourth quarters of these fiscal years.

Termination of our Walmart partnership and wind down of AC Lens operations

Effective as of February 23, 2024, the Company has completed the transition of 229 Walmart Vision Center stores.

Additionally, the agreements governing our provision of contact lens distribution and related services to Walmart and Sam’s Club terminated during the second quarter of 2024 and the Company wound down the majority of AC Lens operations, including the closure of its Ohio distribution center, which largely supported the wholesale distribution and e-commerce contact lens services that the Company provided to Walmart and Sam’s Club.

We have transitioned the order fulfillment functions previously handled by AC Lens to a third-party vendor.

seeking to reduce costs and replace lost business with new America’s Best or Eyeglass World stores and by other means, including pricing actions, we may not be successful in our efforts, which could impact our revenues and profitability.

In fiscal years 2024 and 2023, we have incurred costs in connection with the termination of our partnership with Walmart and related wind down of AC Lens operations.

As a result of the termination of our partnership with Walmart and wind down of AC Lens operations, our former Legacy reportable segment and the majority of our former AC Lens operations as well as related effects of unearned and deferred revenue met the criteria to be presented as discontinued operations.

The plan has been substantially completed and we do not anticipate additional material costs related to this plan.

Refer to Note 2.

“Discontinued Operations” and Note 3.

“Details of Cost Savings Plan” for more information on these costs.

For fiscal years 2025 and 2024, approximately 25% and 24% of our revenue was recorded in the respective fourth quarters, but approximately 26% and 25% of annual SG&A costs were recorded in the respective fourth quarters of these fiscal years.

How We Assess the Performance of Our Business

16 unchanged sentences

The total number of new stores per year and the timing of store openings has, and will continue to have, an impact on our results.

We opened 69 stores during fiscal year 2024.

We opened 33 stores during fiscal year 2025, and we plan to open approximately 30 to 35 new stores in fiscal 2026, primarily comprised of America’s Best stores, after which time we expect to return to our more recent store opening cadence as strategic initiatives begin to take hold.

We will continue to monitor and determine our plans for future new store openings based on health, safety and economic conditions.

Adjusted Comparable Store Sales Growth

We measure Adjusted Comparable Store Sales Growth as the increase or decrease in sales recorded by the comparable store base in any reporting period, compared to sales recorded by the comparable store base in the prior reporting period, which we calculate as follows:

(i) sales are recorded on a cash basis (i.e., when the order is placed and paid for or submitted to a managed care payor, compared to when the order is delivered), utilizing cash basis point of sale information from stores;

(ii) stores are added to the calculation during the 13th full fiscal month following the store’s opening;

(iii) closed stores are removed from the calculation for time periods that are not comparable;

(iv) sales from partial months of operation are excluded when stores do not open or close on the first day of the month;

and (v) when applicable, we adjust for the effect of the 53rd week.

We measure Adjusted Comparable Store Sales Growth as the increase or decrease in sales recorded by the comparable store base in any fiscal reporting period, compared to sales recorded by the comparable store base in the prior fiscal reporting period, which we calculate as follows:

(i) sales are recorded at the point of sale (ii) sales are adjusted for managed care insurance collection estimates;

(iii) stores are added to the calculation during the 13th full fiscal month following the store’s opening;

(iv) closed stores are removed from the calculation for time periods that are not comparable;

(v) sales from partial months of operation are excluded when stores do not open or close on the first day of the month;

and (vi) when applicable, we adjust for the effect of the 53rd week.

Quarterly, year-to-date and annual adjusted comparable store sales are aggregated using only sales from all whole months of operation included in both the current reporting period and the prior reporting period.

28 unchanged sentences

Other expense (income), net (204) (101) (104)

(101) (104) (2,554)

Total operating expenses 1,109,190 1,069,623 997,226

Income (loss) from operations 58,829 (10,359) 24,490

(10,359) 24,490 52,766

Interest expense, net 17,148 16,184 14,339

1 unchanged sentence

Earnings (loss) from continuing operations before income taxes 41,681 (25,684) 9,552

Income tax provision

12,081 1,481 6,006

Income tax provision (benefit)

Income (loss) from continuing operations

29,600 (27,165) 3,546

Income (loss) from continuing operations, net of tax (27,165) 3,546 36,759

Income (loss) from discontinued operations, net of tax (See Note 2) — (1,334) (69,447)

(1,334) (69,447) 5,363

Net income (loss) $ 29,600 $ (28,499) $ (65,901)

$ (28,499) $ (65,901) $ 42,122

Supplemental operating data:

4 unchanged sentences

Diluted earnings (loss) per share from continuing operations $ 0.37 $ (0.35) $ 0.05

$ (0.35) $ 0.05 $ 0.46

Adjusted Diluted EPS from continuing operations (1)

9 unchanged sentences

Income (loss) from continuing operations, net of tax 1.5 % (1.5) % 0.2 %

(1.5) % 0.2 % 2.2 %

Adjusted Operating Income from continuing operations 5.2 % 3.6 % 3.1 %

3.6 % 3.1 % 4.4 %

Adjusted EBITDA from continuing operations 9.7 % 8.5 % 8.1 %

8.5 % 8.1 % 9.7 %

Fiscal Year 2025 compared to Fiscal Year 2024

Certain components of our operations met the requirements to be classified as discontinued operations.

In 2024, certain components of our operations met the requirements to be classified as discontinued operations.

Refer to Note 2 “Discontinued Operations” for information related to our discontinued operations.

Unless otherwise noted, the discussion of U.S.

GAAP results below is based on results from continuing operations.

GAAP results below is based on results from continuing operations, substantially all of which are attributable to our single reportable segment, Owned & Host.

Fiscal 2025 consisted of 53 weeks compared to 52 weeks in fiscal 2024.

The following presents, by segment and by brand, comparable store sales growth, stores open at the end of the period and net revenue for fiscal year 2025 compared to fiscal year 2024.

8 unchanged sentences

Owned & Host segment total 1,250 1,240 $ 1,978,888 99.6 % $ 1,794,247 98.4 %

Other segments revenue

Corporate and other

— — — — 20,972 1.0 % 27,621 1.5 %

Effects of unearned and deferred revenue — — — — (12,372) (0.6) % 1,452 0.1 %

— — — — 1,452 0.1 % (6,816) (0.4) %

Total 5.9 % 1.9 % 1,250 1,240 $ 1,987,488 100.0 % $ 1,823,320 100.0 %

Effect of deferred and unearned revenue on comparable store sales

0.1 % (0.6) %

Adjusted Comparable Store Sales Growth from continuing operations

(1) We calculate total comparable store sales from continuing operations based on consolidated net revenue from continuing operations excluding the impact of (i) other segments revenue, (ii) sales from stores opened less than 13 months, (iii) stores closed in the periods presented, (iv) sales from partial months of operation when stores do not open or close on the first day of the month and (v) if applicable, the impact of a 53rd week in a fiscal year.

Brand-level comparable store sales growth is calculated based on cash basis revenues consistent with what the CODM reviews, and consistent with reportable segment revenues presented in Note 16.

(1) We calculate total comparable store sales from continuing operations based on consolidated net revenue from continuing operations excluding the impact of (i) Corporate and other revenue, (ii) sales from stores opened less than 13 months, (iii) stores closed in the periods presented, (iv) sales from partial months of operation when stores do not open or close on the first day of the month and (v) if applicable, the impact of a 53rd week in a fiscal year.

Brand-level comparable store sales growth is calculated based on point-of-sale revenues consistent with what the CODM reviews, and consistent with reportable segment revenues presented in Note 15.

“Segment Reporting” in our consolidated financial statements.

(2) Percentages reflect line item as a percentage of net revenue, adjusted for rounding.

(3) Adjusted Comparable Store Sales Growth from continuing operations includes the effect of deferred and unearned revenue as if such revenues were earned at the point of sale, resulting in a decrease of 0.6% and a decrease of 0.1% from total comparable store sales growth from continuing operations based on consolidated net revenue from continuing operations for fiscal years 2024 and 2023, respectively.

Total net revenue of $1,987.5 million for fiscal year 2025 increased $164.2 million, or 9.0%, from $1,823.3 million for fiscal year 2024.

Of the increase, approximately 90% was driven by growth from new store sales, approximately 30% was driven by Adjusted Comparable Store Sales Growth from continuing operations and approximately 10% was driven by the timing of unearned revenue, partially offset by approximately 20% from converted and closed stores and 10% from lower revenue from our dedicated e-commerce consumer website, DiscountContacts.com.

Comparable store sales growth and Adjusted Comparable Store Sales Growth from continuing operations for fiscal year 2024 were 1.9% and 1.3%, respectively, both primarily driven by higher average ticket.

During fiscal year 2024, we opened 66 new America’s Best stores and three new Eyeglass World stores and closed 11 America’s Best stores, five Eyeglass World stores, and one Military store as a result of the host partner’s decision to cease its overall operations at the location;

we also converted 24 Eyeglass World Stores to America’s Best stores.

Overall, store count grew 4.4% from the end of fiscal year 2023 to the end of fiscal year 2024 (exclusive of the aforementioned conversions, we had 55 net new America’s Best stores, and two net Eyeglass World stores and one net Military store closed).

Net product sales comprised 80.2% and 81.0% of total net revenue for fiscal years 2024 and 2023, respectively.

Net product sales increased $39.9 million, or 2.8% during fiscal year 2024 compared to fiscal year 2023, primarily due to a $30.7 million, or 2.8%, increase in eyeglass sales, and a $6.0 million, or 2.0%, increase in contact lens sales.

Net sales of services and plans increased $27.0 million, or 8.1%, driven primarily by higher exam revenues of $25.8 million, or 12.4%.

Owned & Host segment net revenue.

Net revenue increased $64.2 million, or 3.7%, driven primarily by new store openings and comparable store sales growth, partially offset by converted and closed stores.

Effects of unearned and deferred revenue.

Unearned and deferred revenue positively impacted net revenue by $8.3 million during fiscal year 2024 compared to fiscal year 2023.

Net revenue was positively impacted by $8.0 million due to the timing of unearned revenue.

Net revenue was positively impacted by $0.3 million due to higher recognition of product protection plan revenue in fiscal year 2024 compared to fiscal year 2023, partially offset by higher sales of club memberships.

Costs applicable to revenue

Costs applicable to revenue of $764.1 million for fiscal year 2024 increased $29.4 million, or 4.0%, from $734.7 million for fiscal year 2023.

As a percentage of net revenue, costs applicable to revenue increased from 41.8% for fiscal year 2023 to 41.9% for fiscal year 2024.

This increase as a percentage of net revenue was primarily driven by lower eyeglass mix of 50 basis points and growth in optometrist-related costs of 40 basis points and other mix and margin effects of 20 basis points.

These costs were partially offset by a 100-basis-point effect from higher exam revenue.

Costs of products as a percentage of net product sales decreased from 29.8% for fiscal year 2023 to 29.6% for fiscal year 2024 primarily driven by other mix and margin effects.

Owned & Host segment costs of products.

Costs of products as a percentage of net product sales decreased from 28.7% for fiscal year 2023 to 28.6% for fiscal year 2024 primarily driven by other mix and margin effects, partially offset by lower eyeglass mix.

Costs of services and plans as a percentage of net sales of services and plans decreased from 93.2% for fiscal year 2023 to 91.9% for fiscal year 2024.

The decrease was primarily driven by higher eye exam revenue, partially offset by growth in optometrist-related costs.

Owned & Host segment costs of services and plans.

Costs of services and plans as a percentage of net sales of services and plans decreased from 93.1% for fiscal year 2023 to 91.8% for fiscal year 2024.

The decrease was primarily driven by higher eye exam revenue, partially offset by growth in optometrist-related costs.

Selling, general and administrative

SG&A of $938.5 million for fiscal year 2024 increased $33.8 million, or 3.7%, from fiscal year 2023.

As a percentage of net revenue, SG&A was 51.5% for fiscal year 2023 compared with 51.5% for fiscal year 2024.

SG&A as a percentage of net revenue was primarily impacted by lower performance-based incentive compensation of 80 basis points, offset by higher occupancy of 30 basis points, as well as legal and professional expenses of 30 basis points and litigation settlement of 20 basis points.

Owned & Host segment SG&A.

SG&A as a percentage of net revenue increased from 38.7% for fiscal year 2023 to 39.5% for fiscal year 2024 driven primarily by higher payroll and occupancy expense.

Depreciation and amortization

Depreciation and amortization expense of $91.3 million for fiscal year 2024 increased $1.5 million, or 1.6%, from $89.9 million for fiscal year 2023 primarily driven by new store openings and investments in remote medicine technology, partially offset by lower depreciation of labs and distribution center.

Asset impairment

We recognized $39.9 million during fiscal year 2024 primarily for impairment related to the Eyeglass World goodwill, Fred Meyer contracts and relationships intangible asset, and tangible long-lived assets and ROU assets associated with our retail stores during fiscal year 2024, compared to $2.7 million recognized in fiscal year 2023.

The impairment of Eyeglass World goodwill was due primarily to reduced projections of future growth and profitability.

The Fred Meyer contracts and relationships intangible asset impairment was due to the decision to close certain Fred Meyer stores in fiscal year 2025.

Refer to Note 5.

Goodwill and Intangible Assets for more details on the Eyeglass World goodwill and Fred Meyer contracts and relationships intangible asset.

The store asset impairment charge is related to our Owned & Host segment and is driven by lower than projected customer sales volume in certain stores, and other entity-specific assumptions and also reflects the effects of certain store closure decisions made as part of the Company’s store optimization review in the current period.

We considered multiple factors including, but not limited to:

forecasted scenarios related to store performance and the likelihood that these scenarios would be ultimately realized;

and the remaining useful lives of the assets.

Asset impairment expenses were recognized in corporate and other.

Interest expense, net

Interest expense, net, of $16.2 million for fiscal year 2024 increased $1.8 million, or 12.9%, from $14.3 million for fiscal year 2023.

The increase was primarily a result of lower income on cash balances of $3.7 million and lower derivative income of $1.3 million, partially offset by lower interest expense on our debt of $2.6 million.

Income tax provision

Our effective tax rates for fiscal year 2024 and fiscal y ear 2023 were (5.8)% and 62.9%, respectively.

The change in effective tax rates reflects our statutory federal and state rate of 25.2% and 25.2%, respectively, the partial disallowance of the Eyeglass World goodwill impairment loss for income tax purposes and other permanent items.

Discontinued Operations

Income (loss) from discontinued operations, net of tax, was $(1.3) million for fiscal year 2024 compared to $(69.4) million for fiscal year 2023.

Net revenue, costs applicable to revenue and SG&A from discontinued operations decreased by $238.6 million, $154.0 million and $65.3 million, respectively, as compared to fiscal year 2023, primarily due to the current year including the discontinued operations results only for a partial period prior to the termination of our partnership with Walmart and the wind-down of AC Lens operations.

Income (loss) from discontinued operations, net of tax also reflects $79.5 million of asset impairment charges in fiscal year 2023 that did not recur in fiscal year 2024.

Income tax benefit increased by $0.9 million, due to lower income (loss) before income taxes in the current period as compared to the prior year and the partial disallowance of the Legacy segment goodwill impairment loss for income tax purposes in the prior year period as well as other permanent items related to discontinued operation.

Fiscal Year 2023 compared to Fiscal Year 2022

Certain components of our operations met the requirements to be classified as discontinued operations.

Refer to Note 2 “Discontinued Operations” for information related to our discontinued operations.

Unless otherwise noted, the discussion of U.S.

GAAP results below is based on results from continuing operations.

The following presents, by segment and by brand, comparable store sales growth, stores open at the end of the period and net revenue for fiscal year 2023 compared to fiscal year 2022.

Comparable store sales growth (1)

Stores open at end of period Net revenue (2)

In thousands, except percentage and store data Fiscal Year 2023 Fiscal Year 2022 Fiscal Year 2023 Fiscal Year 2022 Fiscal Year 2023 Fiscal Year 2022

Owned & Host segment

America’s Best 4.0 % (7.7) % 957 905 $ 1,470,411 83.7 % $ 1,366,019 83.1 %

Eyeglass World (1.0) % (6.7) % 148 136 225,906 12.9 % 217,727 13.2 %

Military 3.0 % (4.3) % 54 54 22,758 1.3 % 22,114 1.3 %

Fred Meyer (4.6) % (5.1) % 29 29 10,973 0.6 % 11,508 0.7 %

Owned & Host segment total 1,188 1,124 $ 1,730,048 98.5 % $ 1,617,368 98.3 %

Other segments revenue

The increase was primarily driven by Adjusted Comparable Store Sales Growth and new store sales, partially offset by closed stores and the timing of unearned revenue.

Unearned and deferred revenue negatively impacted net revenue by $13.8 million during fiscal year 2025 compared to fiscal year 2024, primarily driven by the timing of unearned revenue recognition.

The 53rd week in fiscal 2025 added $35.6 million to net revenue and approximately $0.03 to diluted EPS for the year.

Comparable store sales growth and Adjusted Comparable Store Sales Growth from continuing operations for fiscal year 2025 were 5.9% and 6.0%, respectively, both primarily driven by higher average ticket and continued strength in the Company’s managed care cohort, partially offset by a slight decrease in customer traffic.

During fiscal year 2025, we opened 33 new America’s Best stores and closed 12 America’s Best stores and 11 Fred Meyer stores.

Two of the Fred Meyer stores closed as a result of the host partner’s decision to cease its overall operations at these locations.

Overall, store count grew 0.8% from the end of fiscal year 2024 to the end of fiscal year 2025.

Fiscal Year Ended

(in thousands)

January 3, 2026 December 28, 2024 $ Change

Total net revenue

$ 1,987,488 $ 1,823,320 $ 164,168 9.0 %

Effects of deferred and unearned revenue

Net product sales

$ 1,604,592 $ 1,463,139 $ 141,453 9.7 %

Total 3.4 % (7.3) % 1,188 1,124 $ 1,756,371 100.0 % $ 1,644,675 100.0 %

Adjusted Comparable Store Sales Growth from continuing operations (3)

As a percentage of total net revenue

80.7 % 80.2 %

Brand-level comparable store sales growth is calculated based on cash basis revenues consistent with what the CODM reviews, and consistent with reportable segment revenues presented in Note 16.

“Segment Reporting” in our consolidated financial statements.

(2) Percentages reflect line item as a percentage of net revenue, adjusted for rounding.

(3) Adjusted Comparable Store Sales Growth from continuing operations includes the effect of deferred and unearned revenue as if such revenues were earned at the point of sale, resulting in a decrease of 0.1% and 0.2% from total comparable store sales growth from continuing operations based on consolidated net revenue from continuing operations for fiscal year 2023 and 2022, respectively.

Total net revenue of $1,756.4 million for fiscal year 2023 increased $111.7 million, or 6.8%, from $1,644.7 million for fiscal year 2022.

The increase was driven by approximately 60% from new store openings and 50% from Adjusted Comparable Store Sales Growth from continuing operations, partially offset by closed stores and effects of deferred and unearned revenue.

Comparable store sales growth and Adjusted Comparable Store Sales Growth from continuing operations for fiscal year 2023 were 3.4% and 3.3%, respectively, both reflecting an increase in customer transactions and higher average ticket.

During fiscal year 2023, we opened 58 new America’s Best stores and 12 new Eyeglass World stores and closed six America’s Best stores.

The total net new locations in fiscal year 2023 for America’s Best and Eyeglass World were 52 and 12, respectively.

Overall, store count grew 5.7% from the end of fiscal year 2022 to the end of fiscal year 2023.

Net product sales comprised 81.0% and 81.5% of total net revenue for fiscal years 2023 and 2022, respectively.

Net product sales increased $82.9 million, or 6.2% during fiscal year 2023 compared to fiscal year 2022, primarily due to a $68.8 million, or 6.6%, increase in eyeglass sales and a $12.6 million, or 4.4%, increase in contact lens sales.

Net sales of services and plans

$ 382,896 $ 360,181 $ 22,715 6.3 %

As a percentage of total net revenue

19.3 % 19.8 %

Net product sales increased $141.5 million, or 9.7% during fiscal year 2025 compared to fiscal year 2024, primarily due to pricing and product mix initiatives in eyeglass sales of $123.4 million, or 10.8% , contact lens sales of $16.9 million, or 5.5%, and other add-on sales.

Net sales of services and plans increased $22.7 million, or 6.3%, driven primarily by higher exam revenues of $21.1 million, or 9.0%.

Owned & Host segment net revenue.

Net revenue increased $112.7 million, or 7.0%, driven primarily by new store openings and comparable store sales growth.

Effects of unearned and deferred revenue.

Unearned and deferred revenue negatively impacted net revenue by $0.8 million during fiscal year 2023 compared to fiscal year 2022.

Net revenue was positively impacted by $4.4 million due to the timing of unearned revenue.

Net revenue was negatively impacted by $5.2 million due to higher sales of club memberships and product protection plans, and lower recognition of product protection plan revenue in fiscal year 2023 compared to fiscal year 2022.

Costs applicable to revenue

Fiscal Year Ended

(in thousands)

January 3, 2026 December 28, 2024 $ Change

Total costs applicable to revenue

$ 819,469 $ 764,056 $ 55,413 7.3 %

As a percentage of total net revenue

41.2 % 41.9 %

Total costs of products

$ 461,213 $ 433,194 $ 28,019 6.5 %

As a percentage of net product sales

28.7 % 29.6 %

Total costs of services and plans

$ 358,256 $ 330,862 $ 27,394 8.3 %

As a percentage of net sales of services and plans

93.6 % 91.9 %

Costs applicable to revenue of $819.5 million for fiscal year 2025 increased $55.4 million, or 7.3%, from $764.1 million for fiscal year 2024.

As a percentage of net revenue, costs applicable to revenue increased from 40.6% for fiscal year 2022 to 41.8% for fiscal year 2023.

This increase as a percentage of net revenue was primarily driven by higher growth in optometrist-related costs of 160 basis points and by 60 basis points due to reduction in components of service revenue, including product protection plan revenue, and other mix and margin effects.

These costs were partially offset by a 100-basis point effect from higher exam revenue.

Costs of products as a percentage of net product sales decreased from 30.0% for fiscal year 2022 to 29.8% for fiscal year 2023 primarily driven by increased eyeglass mix and higher eyeglass margin.

Owned & Host segment costs of products.

Costs of products as a percentage of net product sales decreased from 28.9% for fiscal year 2022 to 28.7% for fiscal year 2023 primarily driven by increased eyeglass mix and higher eyeglass margin.

Costs of services and plans as a percentage of net sales of services and plans increased from 87.3% for fiscal year 2022 to 93.2% for fiscal year 2023.

The increase was primarily driven by higher growth in optometrist-related costs and lower product protection plans revenues, partially offset by higher eye exam revenue.

Owned & Host segment costs of services and plans.

Costs of services and plans as a percentage of net sales of services and plans increased from 88.6% for fiscal year 2022 to 93.1% for fiscal year 2023.

The increase was primarily driven by higher growth in optometrist-related costs, partially offset by higher eye exam revenue.

As a percentage of net revenue, costs applicable to revenue decreased 70 basis points primarily driven by eyeglass mix and margin improvement of 140 basis points related to a successful execution of pricing and product mix initiatives and leveraging of optometrist-related costs of 10 basis points, partially offset by lower contact lens margin of 20 basis points and other mix and margin effects of 60 basis points.

Costs of products as a percentage of net product sales decreased 90 basis points primarily driven by eyeglass mix and margin improvement related to a successful execution of pricing and product mix initiatives, partially offset by lower contact lens margin.

Costs of services and plans as a percentage of net sales of services and plans increased 170 basis points primarily driven by lower growth in add-ons and eye exam revenues relative to the growth in optometrist-related costs.

Selling, general and administrative

Fiscal Year Ended

(in thousands)

January 3, 2026 December 28, 2024 $ Change

$ 1,016,251 $ 938,524 $ 77,727 8.3 %

As a percentage of total revenue 51.1 % 51.5 %

SG&A of $1,016.3 million for fiscal year 2025 increased $77.7 million, or 8.3%, from fiscal year 2024.

As a percentage of net revenue, SG&A increased from 50.6% for fiscal year 2022 to 51.5% for fiscal year 2023.

The increase in SG&A as a percentage of net revenue was primarily driven by higher performance-based incentive compensation of 80 basis points, higher payroll of 50 basis points, as well as 20 basis points of other expenses, such as stock-based compensation expense, partially offset by lower advertising expense of 60 basis points.

Owned & Host segment SG&A.

SG&A as a percentage of net revenue decreased from 38.9% for fiscal year 2022 to 38.7% for fiscal year 2023 driven primarily by lower advertising expense, partially offset by higher payroll.

SG&A as a percentage of net revenue decreased 40 basis points and was primarily impacted by improved leverage of advertising investments and other expenses of 170 basis points, which included an offset from higher healthcare expenses.

These were partially offset by increases in variable incentive compensation expenses of 100 basis points and an increase in stock-based compensation of 30 basis points primarily related to revenue and profitability growth.

Depreciation and amortization

Depreciation and amortization expense of $89.9 million for fiscal year 2023 increased $1.2 million, or 1.3%, from $88.7 million for fiscal year 2022 primarily driven by an increase in investments in remote medicine technology and new store openings, partially offset by a shift to cloud-based software investments that are amortized in SG&A.

Depreciation and amortization expense of $91.2 million for fiscal year 2025 decreased $0.2 million, or 0.2%, from $91.3 million for fiscal year 2024 primarily driven by fewer new store openings, partially offset by higher depreciation related to investments in existing stores.

Asset impairment

We recorded impairment charges of $2.7 million for fiscal year 2023 compared to $5.5 million recognized in fiscal year 2022, related to tangible long-lived assets and ROU assets associated with our Owned & Host segment, which were driven by lower than projected customer sales volume in certain stores, and other entity-specific assumptions.

We considered multiple factors including, but not limited to:

forecasted scenarios related to store performance and the likelihood that these scenarios would be ultimately realized;

and the remaining useful lives of the assets.

We recognized $2.0 million of impairment charges during fiscal year 2025 primarily for tangible long-lived assets and right of use (“ROU”) assets associated with our retail stores.

We recognized $39.9 million of impairment charges in fiscal year 2024, primarily for the Eyeglass World goodwill and Fred Meyer contracts and relationships intangible asset, and tangible long-lived assets and ROU assets associated with our retail stores.

Asset impairment expenses were recognized in Corporate and other.

Other expense (income), net

Other expense (income), net was $(0.1) million for fiscal year 2023 compared to $(2.6) million for fiscal year 2022.

This change was primarily a result of a gain of $2.7 million in Other expense (income), net in fiscal year 2022 that did not occur in fiscal year 2023 in connection with the acquisition of our equity method investee by a third party.

“Business and Significant Accounting Policies” for further details.

Refer to Note 12 “Fair Value Measurement” and Note 4 “Goodwill and Intangible Assets” for further details.

Interest expense, net

Interest expense, net, of $14.3 million for fiscal year 2023 increased $13.9 million from $0.5 million for fiscal year 2022.

The increase was primarily a result of lower derivative income of $15.8 million and higher Term Loan A expense of $5.4 million, partially offset by higher income on cash balances of $6.8 million.

Interest expense, net, of $17.1 million for fiscal year 2025 increased $1.0 million, or 6.0%, from $16.2 million for fiscal year 2024.

The change was primarily a result of lower income on cash balances of $3.8 million, partially offset by lower interest expense on our debt of $2.7 million.

Income tax provision

Our effective tax rates for fiscal year 2023 and fiscal year 2022 were 62.9% and 29.7%, respectively.

The change in effective tax rates reflects our statutory federal and state rate of 25.2% and 25.4%, respectively, tax impacts of consolidated VIEs and non-deductible compensation expense as well as effects of other permanent items.

Our effective tax rates for fiscal year 2025 and fiscal y ear 2024 were 29.0% and (5.8)%, respectively.

The change in effective tax rates reflects our statutory federal and state rate of 25.1% and 25.2%, respectively, the tax impacts of the partial disallowance of Eyeglass World goodwill impairment loss for income tax purposes and other effects of permanent items.

Refer to Note 7 "Income Taxes" for further details.

Discontinued Operations

Income (loss) from discontinued operations, net of tax, was $(69.4) million for fiscal year 2023 compared to $5.4 million for fiscal year 2022.

Net revenue, costs applicable to revenue, and SG&A from discontinued operations increased by $9.4 million, $8.3 million, $4.4 million, respectively, as compared to fiscal year 2022.

The revenue increase was primarily driven by increases in wholesale fulfillment.

Income (loss) from discontinued operations, net of tax also reflects $79.4 million of asset impairment charges in fiscal year 2023 due to impairments of goodwill, intangible assets, and tangible long-lived assets in connection with the termination of the Walmart partnership and the wind-down of AC Lens operations.

Year over year changes in the income tax provision (benefit) reflect lower income (loss) before income taxes in fiscal year 2023 as compared to fiscal year 2022, the disallowance of the Legacy segment goodwill impairment loss for income tax purposes in fiscal year 2023 as well as other permanent items related to discontinued operations.

Loss from discontinued operations, net of tax, of $1.3 million for fiscal year 2024 represents loss prior to the termination of our partnership with Walmart and the wind-down of the AC Lens operations.

There were no discontinued operations results for fiscal year 2025.

Fiscal Year 2024 compared to Fiscal Year 2023

For a comparison of our results of operations for the years ended December 28, 2024 to December 30, 2023, see "Part II, Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations" of our annual report on Form 10-K for the fiscal year ended December 28, 2024, filed with the SEC on February 26, 2025.

Non-GAAP Financial Measures

Adjusted Operating Income, Adjusted Operating Margin, EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted Diluted EPS

We define Adjusted Operating Income as net income (loss), plus interest expense (income), net and income tax provision (benefit), further adjusted to exclude stock-based compensation expense, (gain) loss on extinguishment of debt, asset impairment, litigation settlement, secondary offering expenses, management realignment expenses, long-term incentive plan expenses, ERP and CRM implementation expenses and certain other expenses.

We define Adjusted Operating Income as net income (loss), plus interest expense (income), net and income tax provision (benefit), further adjusted to exclude stock-based compensation expense, (gain) loss on extinguishment of debt, asset impairment, litigation settlement, secondary offering expenses, management realignment expenses, long-term incentive plan expenses, amortization of acquisition intangibles, ERP and CRM implementation expenses, shareholder activism costs, severance and associate-related costs associated with organizational restructuring and certain other expenses.

We define Adjusted Operating Margin as Adjusted Operating Income as a percentage of net revenue.

We define EBITDA as net income (loss), plus interest expense (income), net, income tax provision (benefit) and depreciation and amortization.

We define Adjusted EBITDA as net income (loss), plus interest expense (income), net, income tax provision (benefit) and depreciation and amortization, further adjusted to exclude stock-based compensation expense, (gain) loss on extinguishment of debt, asset impairment, litigation settlement, secondary offering expenses, management realignment expenses, long-term incentive plan expenses, ERP and CRM implementation expenses and certain other expenses.

We define Adjusted EBITDA Margin as Adjusted EBITDA as a percentage of net revenue.

We define Adjusted Diluted EPS as diluted earnings (loss) per share, adjusted for the per share impact of stock-based compensation expense, (gain) loss on extinguishment of debt, asset impairment, litigation settlement, secondary offering expenses, management realignment expenses, long-term incentive plan expenses, amortization of debt discounts and deferred financing costs of our term loan borrowings, amortization of the conversion feature and deferred financing costs related to our 2025 N otes when not required under U.S.

GAAP to be added back for diluted earnings (loss) per share, derivative fair value adjustments, ERP and CRM implementation expenses, certain other expenses, less the tax effect of these adjustments including tax expense (benefit) from stock-based compensation.

GAAP to be added back for diluted earnings (loss) per share, derivative fair value adjustments, ERP and CRM implementation expenses, shareholder activism costs, severance and associate-related costs associated with organizational restructuring, and certain other expenses, less the tax effect of these adjustments including tax expense (benefit) from stock-based compensation.

When presenting Adjusted Operating Income from continuing operations, EBITDA from continuing operations and Adjusted EBITDA from continuing operations we use the same definitions for Adjusted Operating Income, EBITDA and Adjusted EBITDA, respectively, and also exclude income (loss) from discontinued operations, net of tax.

33 unchanged sentences

Net income (loss) $ 29,600 1.5 % $ (28,499) (1.6) % $ (65,901) (3.8) %

$ (28,499) (1.6) % $ (65,901) (3.8) % $ 42,122 2.6 %

Income (loss) from discontinued operations, net of tax — — % (1,334) (1.0) % (69,447) (18.8) %

(1,334) (1.0) % (69,447) (18.8) % 5,363 1.5 %

Income (loss) from continuing operations, net of tax 29,600 1.5 % (27,165) (1.5) % 3,546 0.2 %

(27,165) (1.5) % 3,546 0.2 % 36,759 2.2 %

Interest expense, net 17,148 0.9 % 16,184 0.9 % 14,339 0.8 %

16,184 0.9 % 14,339 0.8 % 462 0.0 %

Income tax provision 12,081 0.6 % 1,481 0.1 % 6,006 0.3 %

7 unchanged sentences

1,903 0.1 % 4,450 0.2 % — — %

ERP and CRM implementation expenses (g)

Amortization of acquisition intangibles (e)

677 — % 1,313 0.1 % 1,525 0.1 %

ERP and CRM implementation expenses (h)

6,420 0.3 % 5,990 0.3 % 484 — %

Adjusted Operating Income from continuing operations / Adjusted Operating Margin from continuing operations

8,962 0.5 % 7,536 0.4 % 5,493 0.3 %

Adjusted Operating Income from continuing operations / Adjusted Operating Margin from continuing operations $ 102,468 5.2 % $ 65,489 3.6 % $ 53,894 3.1 %

Percentages reflect line item as a percentage of net revenue, adjusted for rounding.

Some of the percentage totals in the table above do not foot due to rounding differences.

In thousands Fiscal Year 2025 Fiscal Year 2024 Fiscal Year 2023

Net income (loss) $ 29,600 1.5 % $ (28,499) (1.6) % $ (65,901) (3.8) %

$ (28,499) (1.6) % $ (65,901) (3.8) % $ 42,122 2.6 %

Income (loss) from discontinued operations, net of tax — — % (1,334) (1.0) % (69,447) (18.8) %

(1,334) (1.0) % (69,447) (18.8) % 5,363 1.5 %

Income (loss) from continuing operations, net of tax 29,600 1.5 % (27,165) (1.5) % 3,546 0.2 %

(27,165) (1.5) % 3,546 0.2 % 36,759 2.2 %

Interest expense, net 17,148 0.9 % 16,184 0.9 % 14,339 0.8 %

16,184 0.9 % 14,339 0.8 % 462 — %

Income tax provision 12,081 0.6 % 1,481 0.1 % 6,006 0.3 %

1 unchanged sentence

EBITDA from continuing operations 149,981 7.5 % 81,849 4.5 % 113,765 6.5 %

81,849 4.5 % 113,765 6.5 % 141,456 8.6 %

Stock-based compensation expense (a)

6 unchanged sentences

1,903 0.1 % 4,450 0.2 % — — %

ERP and CRM implementation expenses (g)

ERP and CRM implementation expenses (h)

6,420 0.3 % 5,990 0.3 % 484 — %

1 unchanged sentence

Adjusted EBITDA from continuing operations / Adjusted EBITDA Margin from continuing operations $ 192,943 9.7 % $ 155,525 8.5 % $ 142,237 8.1 %

$ 155,525 8.5 % $ 142,237 8.1 % $ 159,322 9.7 %

Percentages reflect line item as a percentage of net revenue, adjusted for rounding.

Some of the percentage totals in the table above do not foot due to rounding differences.

In thousands, except per share amounts Fiscal Year 2025 Fiscal Year 2024 Fiscal Year 2023

1 unchanged sentence

Diluted EPS from discontinued operations — (0.02) (0.88)

(0.02) (0.88) 0.07

Diluted EPS from continuing operations 0.37 (0.35) 0.05

(0.35) 0.05 0.46

Stock-based compensation expense (a)

5 unchanged sentences

Litigation settlement (d)

Amortization of debt discounts and deferred financing costs (e)

Amortization of acquisition intangibles (e)

0.01 0.02 0.02

Derivative fair value adjustments (f)

Amortization of debt discounts and deferred financing costs (f)

0.02 0.03 0.04

ERP and CRM implementation expenses (g)

Derivative fair value adjustments (g)

ERP and CRM implementation expenses (h)

0.08 0.08 0.01

Tax effects (i)

0.12 0.10 0.07

Adjusted Diluted EPS from continuing operations

Tax effects (j)

(0.13) (0.19) (0.12)

Adjusted Diluted EPS from continuing operations $ 0.80 $ 0.52 $ 0.47

Weighted average diluted shares outstanding 80,576 78,592 78,596

Some of the totals in the table above may not foot due to rounding differences.

Some of the totals in the table above do not foot due to rounding differences.

(a) Non-cash charges related to stock-based compensation programs, which vary from period to period depending on the timing of awards and performance vesting conditions.

2 unchanged sentences

(d) Expenses associated with settlement of certain litigation.

(e) Amortization of deferred financing costs and other non-cash charges related to our debt.

(e) Amortization of the increase in carrying values of finite-lived intangible assets resulting from the purchase accounting following the acquisition of the Company by affiliates of KKR & Co.

(f) Amortization of deferred financing costs and other non-cash charges related to our debt.

We adjust for amortization of deferred financing costs related to the 2025 Notes only when adjustment for these costs is not required in the calculation of diluted earnings per share under U.S.

(f) The adjustments for the derivative fair value (gains) and losses have the effect of adjusting the (gain) or loss for changes in the fair value of derivative instruments and amortization of AOCL for derivatives not designated as accounting hedges.

(g) The adjustments for the derivative fair value (gains) and losses have the effect of adjusting the (gain) or loss for changes in the fair value of derivative instruments and amortization of AOCL for derivatives not designated as accounting hedges.

This results in reflecting derivative (gains) and losses within Adjusted Diluted EPS during the period the derivative is settled.

(g) Costs related to the Company’s ERP and CRM implementation.

(h) Other adjustments include amounts that management believes are not representative of our operating performance (amounts in brackets represent reductions in Adjusted Operating Income, Adjusted Diluted EPS and Adjusted EBITDA), which are primarily related to costs associated with the digitization of paper-based records of $5.8 million and $2.2 million for fiscal years 2024 and 2023, respectively, costs related to an early lease termination of $0.7 million for fiscal year 2024 and our share of (gains) losses on equity method investment of $(2.7) million for fiscal year 2022, other expenses and adjustments.

Other adjustments for both Adjusted Operating Income and Adjusted Diluted EPS include amortization of the increase in carrying values of finite-lived intangible assets resulting from the application of purchase accounting following the acquisition of the Company by affiliates of KKR & Co.

Adjusted Diluted EPS is also adjusted to include debt issuance costs.

(i) Represents the income tax effect of the total adjustments at our combined statutory federal and state income tax rates, excluding a portion of Eyeglass World goodwill impairment charge, which was disallowed for income tax purposes, and including tax expense (benefit) from stock-based compensation.

(h) Costs related to the Company’s ERP and CRM implementation.

(i) Other adjustments include amounts that management believes are not representative of our operating performance (amounts in brackets represent reductions in Adjusted Operating Income, Adjusted Diluted EPS and Adjusted EBITDA), which are primarily related to costs associated with the digitization of paper-based records of $2.2 million, $5.8 million and $2.2 million for fiscal years 2025, 2024 and 2023, respectively, severance and associate-related costs related to organizational restructuring of $3.6 million and shareholder activism of $2.1 million for fiscal year 2025, and other expenses and adjustments.

(j) Represents the income tax effect of the total adjustments at our combined statutory federal and state income tax rates, excluding a portion of Eyeglass World goodwill impairment charge, which was disallowed for income tax purposes in fiscal year 2024, and including tax expense (benefit) from stock-based compensation.

Liquidity and Capital Resources

4 unchanged sentences

We continue to be focused on these items in addition to other key measures we use to determine how our consolidated business and operating segments are performing.

We believe that cash on hand, cash expected to be generated from

operations and the availability of borrowings under our revolving credit facility will be sufficient to fund our working capital requirements, liquidity obligations, anticipated capital expenditures and payments due under our existing debt for the next 12 months and thereafter for the foreseeable future.

We believe that cash on hand, cash expected to be generated from operations and the availability of borrowings under our revolving credit facility will be sufficient to fund our working capital requirements, liquidity obligations, anticipated capital expenditures and payments due under our existing debt for the next 12 months and

thereafter for the foreseeable future.

Depending on our liquidity levels, conditions in the capital markets and other factors, we may from time to time consider the prepayment, refinancing or issuance of debt, issuance of equity or other securities, the proceeds of which could provide additional liquidity for our operations, as well as modifications to our Term Loan A where possible.

In August 2024, we established an incremental term loan in the amount of $115.0 million and used the proceeds of this borrowing in addition to cash on hand to repurchase $217.7 million of aggregate principal amount of the 2025 Notes.

In August 2024, we incurred an incremental term loan in the amount of $115.0 million and used the proceeds in addition to cash on hand to repurchase $217.7 million aggregate principal amount of the 2025 Notes.

In May 2025, we fully repaid the remaining $84.8 million principal balance of the 2025 Notes using a combination of cash on hand and borrowings from our Revolving Loans.

Later, in 2025, we fully repaid our balance outstanding under our Revolving Loans.

Refer to Note 5.

"Debt" for more information.

Depending on market conditions and other factors, we may elect to repurchase all or a significant portion of our 2025 Notes outstanding principal balance of $84.8 million prior to their maturity on May 15, 2025, utilizing cash on hand and/or one or more of the additional liquidity sources noted above.

Our ability to maintain sufficient liquidity may be affected by numerous factors, many of which are outside of our control.

1 unchanged sentence

Our working capital requirements for inventory will increase as we continue to open additional stores.

As of fiscal year end 2024, we had $73.9 million in cash and cash equivalents and $293.6 million of availability under our revolving credit facility, which includes $6.4 million in outstanding letters of credit.

During the fourth quarter of 2025, we entered into an interest rate swap with a notional amount of $100.0 million to mitigate the variability of cash flows associated with these interest payments.

“Interest Rate Derivatives” for additional information.

As of fiscal year end 2025, we had $38.7 million in cash and cash equivalents and $293.3 million of availability under our revolving credit facility, net of $6.7 million in outstanding letters of credit.

The following table summarizes cash flows provided by (used for) operating activities, investing activities and financing activities for the periods indicated:

4 unchanged sentences

Financing activities (104,622) (113,345) (136,808)

Net increase (decrease) in cash, cash equivalents and restricted cash $ (75,790) $ (79,597) $ (76,252)

Net change in cash, cash equivalents and restricted cash

$ (34,935) $ (75,790) $ (79,597)

Net Cash Provided by Operating Activities

Cash flows provided by operating activities decreased by $39.4 million to $133.6 million, during fiscal year 2024 from $173.0 million during fiscal year 2023 as a result of a decrease in non-cash reconciling items of $56.3 million and changes in net working capital and other assets and liabilities of $20.5 million, partially offset by an increase in net income of $37.4 million as compared to fiscal year 2023.

Both the increase in net income and decrease in non-cash adjustments were primarily driven by the termination of the Walmart partnership and related impairment charges of $79.7 million in the prior year period, partially offset by impairments of long-lived assets and intangible assets of $40.1 million in the current year period.

Decreases in other liabilities used $50.3 million in year-over-year cash primarily due to decreases in compensation related accruals.

Decreases in accounts payable used $16.2 million in year-over year cash.

These were partially offset by decreases in trade receivables which contributed $44.2 million in year-over-year cash and decreases in inventories which contributed $22.1 million in year-over-year cash during fiscal year 2024.

These changes in working capital during fiscal year 2024 are primarily due to the AC Lens wind down and the Walmart partnership termination.

Cash flows provided by operating activities increased by $53.8 million to $173.0 million, during fiscal year 2023 from $119.2 million during fiscal year 2022 as a result of changes in net working capital and other assets and liabilities, which contributed an additional $81.9 million in cash, partially offset by a decrease in net income and non-cash reconciling items of $28.0 million as compared to fiscal year 2022.

Working capital was most significantly impacted by changes in other liabilities and accounts receivable.

Increases in other liabilities contributed $54.6 million in year-over-year cash primarily due to increases in compensation related accruals.

Decreases in accounts receivable balances contributed $17.0 million in year-over-year cash primarily due to payments of deferred social security taxes in fiscal year 2022 pursuant to the CARES Act that did not recur in fiscal year 2023, and a decrease in managed care receivables due to timing.

Cash flows provided by operating activities increased by $12.6 million to $146.3 million, during fiscal year 2025 from $133.6 million during fiscal year 2024 as a result of an increase in net income of $58.1 million.

This was partially offset by changes in net working capital and other assets and liabilities of $30.8 million and a decrease in non-cash adjustments items of $14.7 million primarily driven by a decrease in asset impairment, partially offset by increases in deferred income taxes and stock-based compensation.

Working capital was primarily impacted by changes in trade receivables, other assets, inventory, accounts payable, other liabilities, and timing of unearned and deferred revenue.

Changes in trade receivables used $44.5 million more in cash and were primarily driven by changes in sales.

Changes in other assets used $38.4 million more in cash, primarily due to increased cloud-based software assets.

Changes in inventories used $22.3 million more in cash due to product mix initiatives.

These were partially offset by changes in accounts payable, which contributed $39.3 million more in cash.

Changes in other liabilities contributed $16.0 million more in cash primarily due to increases in compensation-related and other accruals.

The timing of unearned and deferred revenue contributed $18.6 million more in cash.

Year-over-year changes in working capital were also impacted by the AC Lens wind down and the termination of the Walmart partnership in 2024 that did not recur in 2025.

Net Cash Used for Investing Activities

Net cash used for investing activities decreased by $19.5 million, to $76.6 million, during fiscal year 2025 from $96.1 million during fiscal year 2024.

The decrease was primarily due to lower investments in doctor and in-store lab equipment, labs and distribution center, and new stores.

We purchased $95.5 million in capital items during fiscal year 2024.

Approximately 80% to 85% of our capital spend is related to our expected growth (i.e., new stores, remote medicine infrastructure, EHR, optometric equipment, additional capacity in our optical laboratories and distribution centers, and our IT infrastructure and omni-channel platform related investments).

Net cash used for investing activities increased by $4.9 million, to $115.8 million, during fiscal year 2023 from $110.9 million during fiscal year 2022.

The increase was primarily due to investments in our labs and distribution centers, and store remodeling costs, partially offset by decreased investments in remote medicine.

We purchased $114.8 million in capital items during fiscal year 2023.

The decrease was primarily due to lower store openings, partially offset by higher investments in doctor and other in-store equipment in existing stores.

Net Cash Provided by (Used for) Financing Activities

Net cash used for financing activities decreased $8.7 million, from $113.3 million use of cash during fiscal year 2024 to $104.6 million use of cash during fiscal year 2025.

The decrease in cash used for financing activities was primarily due to an increase in proceeds from long-term debt related to the additional borrowings of $115.0 million and decreases in purchases of treasury stock of $25.3 million partially offset by increased principal payments of debt due to the repurchase of $217.7 million aggregate principal amount of the 2025 Notes for an aggregate cash repurchase price of $215.0 million in fiscal year 2024 as compared with the repurchase of the 2025 Notes for $99.3 million in fiscal year 2023.

Net cash used for financing activities increased $52.3 million, from $84.6 million use of cash during fiscal year 2022 to $136.8 million use of cash during fiscal year 2023.

The increase in cash used for financing activities was primarily due to a repurchase of $100.0 million aggregate principal amount of the 2025 Notes for an aggregate cash repurchase price of $99.3 million in fiscal year 2023, partially offset by decreases in purchases of treasury stock of $56.0 million during fiscal year 2023 as compared with 2022.

The following table sets forth the amounts owed under our term loan and the 2025 Notes and the interest rate on such outstanding amounts, and the amount available for additional borrowing thereunder, as of the end of fiscal year 2024:

The $8.7 million decrease was primarily due to borrowings on the Revolving Loans of $25.0 million offset by a repayment of $84.8 million of the 2025 Notes and $25.0 million of Revolving Loans in fiscal year 2025 as compared to a prepayment of $217.7 million aggregate principal amount of the 2025 Notes for an aggregate cash repurchase price of $215.0 million, which was partially offset by additional term loan borrowings of $115.0 million in fiscal year 2024.

The following table sets forth the amounts owed under our term loan and the interest rate on such outstanding amount, and the amount available for additional borrowing thereunder, as of the end of fiscal year 2025:

In thousands Interest Rate (2)

Amount Outstanding Amount Available for Additional Borrowing

2025 Notes, due May 15, 2025 Fixed $ 84,774 $ —

Term Loan A, due June 13, 2028

Variable 254,188 —

Term Loan A, due June 13, 2028 Variable $ 237,625 $ —

Revolving Loans, due June 13, 2028 (1)

1 unchanged sentence

Total $ 237,625 $ 293,300

(1) At December 28, 2024, the amount available under our revolving credit facility reflected a reduction of $6.4 million of letters of credit outstanding.

(1) At January 3, 2026, the amount available under our revolving credit facility reflected a reduction of $6.7 million of letters of credit outstanding.

(2) Refer to Note 5.

Debt for the interest rates used on the term loan and revolving credit facility.

The 2025 Notes pay interest semi-annually in arrears on May 15 and November 15 of each year, commencing on November 15, 2020, at an annual rate of 2.50%.

Share Repurchase Authority

Effective November 8, 2021, the Company's Board of Directors authorized the Company to repurchase up to $50 million aggregate amount of shares of the Company's common stock.

On November 29, 2021, the Company’s Board of Directors authorized an increase from $50 million to $100 million in aggregate amount of shares of the Company’s common stock that may be repurchased under the Company’s current share repurchase program.

On February 23, 2022, our Board of Directors authorized a $100 million increase to the share repurchase authorization, for a total authorization of $200 million.

On February 23, 2022, our Board of Directors authorized a $100 million increase to the share repurchase authorization, resulting in total authorization of $200 million.

During fiscal year 2023, the Company repurchased 1.1 million shares of its common stock for $25 million under the share repurchase program.

The Company’s original share repurchase authorization expired on December 30, 2023, and had remaining capacity of $25 million.

Effective February 23, 2024, the Board authorized the Company to repurchase up to $50 million aggregate amount of shares of the Company’s common stock until January 3, 2026.

As of December 28, 2024, $50 million remains available under the share repurchase authorization.

During fiscal years 2023 and 2022, the Company repurchased 1.1 million shares of its common stock for $25 million and 2.7 million shares of its common stock for $80 million, respectively, under the share repurchase program.

authorization permits the Company to make purchases of its common stock from time to time in the open market or privately negotiated transactions, and pursuant to pre-set trading plans meeting the requirements of all applicable securities laws and regulations.

No additional shares were repurchased in fiscal years 2024 and 2025.

The share repurchase authorization expired on January 3, 2026, and had remaining capacity of $50 million.

Effective March 2, 2026, the Board authorized the Company to repurchase up to $50 million aggregate amount of shares of the Company’s common stock until December 28, 2030.

The authorization permits the Company to make purchases of its common stock from time to time in the open market or privately negotiated transactions, and pursuant to pre-set trading plans meeting the requirements of all applicable securities laws and regulations.

The timing and amounts of any such repurchases will depend on a variety of factors, including the market price of the Company’s shares, general market and economic conditions, legal requirements and tax implications.

6 unchanged sentences

Total $ 72,840 $ 95,505 $ 114,774

We expect capital expenditures in fiscal year 2025 to be approximately between $90 million and $95 million and to be used primarily in supporting the Company’s growth through investments in new and existing stores, remote medicine, EHR, optical laboratories, and IT infrastructure.

We expect capital expenditures in fiscal year 2026 to be approximately between $73 million and $78 million and to be used primarily in supporting the Company’s growth through investments in new and existing stores, and IT infrastructure.

We expect to fund capital expenditures with cash flows from operations, but may also use existing cash balances or funds available through our revolving credit facility.

2 unchanged sentences

In thousands 2026 2027 2028 2029 2030 Thereafter Total

2025 Notes (a)

$ 84,774 $ — $ — $ — $ — $ — $ 84,774

Term loan (b)

Term loan (a)

$ 13,250 $ 13,250 $ 211,125 $ — $ — $ — $ 237,625

Revolving credit facility (c)

Revolving credit facility (b)

— — — — — — —

Estimated interest (d)

Estimated interest (c)

12,266 10,976 4,816 — — — 28,058

Noncancelable operating leases (e)

Noncancelable operating leases (d)

110,992 102,659 80,021 70,742 53,573 111,690 529,677

Finance leases (f)

Finance leases (e)

4,249 3,370 1,959 612 273 136 10,599

Other commitments (g)

Other commitments (f)

79,975 43,561 27,631 18,092 4,244 749 174,252

1 unchanged sentence

(a) Refer to Note 5.

“Debt” for more information on the 2025 Notes and Note 15.

“Earnings Per Share” for the treatment of earnings per share in relation to the 2025 Notes.

(b) Refer to Note 6.

“Debt” to our consolidated financial statements for more information on our term loan.

(b) Refer to Note 5.

“Debt” for more information on our revolving credit facility.

(d) We have estimated our interest payments on our term loan based on Term Secured Overnight Financing Rate as of the end of fiscal year 2024.

(c) We have estimated our interest payments on our term loan based on Term Secured Overnight Financing Rate as of the end of fiscal year 2025.

Amounts and timing may be different from our estimated interest payments due to potential voluntary prepayments, borrowings and interest rate fluctuations.

(e) We lease our retail stores, optometric examination offices, distribution centers, office space and all of our optical laboratories with the exception of our St.

Cash flows related to our hedging instruments are excluded from estimated interest presented in the table above.

(d) We lease our retail stores, optometric examination offices, distribution centers, office space and all of our optical laboratories with the exception of our St.

Cloud, Minnesota lab, which we own.

5 unchanged sentences

“Leases” for our current and long-term lease payment obligations.

(f) For leases classified as finance leases, the finance lease asset is recorded as property and equipment and a corresponding amount is recorded as a long-term debt obligation in the Consolidated Balance Sheets at the net present value of the minimum lease payments to be made over the lease term for new finance leases.

(e) For leases classified as finance leases, the finance lease asset is recorded as property and equipment and a corresponding amount is recorded as a long-term debt obligation in the Consolidated Balance Sheets at the net present value of the minimum lease payments to be made over the lease term for new finance leases.

We allocate each lease payment between a reduction of the lease obligation and interest expense using the effective interest method.

2 unchanged sentences

“Leases” for our current and long-term lease payment obligations.

(g) Other commitments include minimum purchase commitments with certain trade vendors and contractual agreements to purchase goods or services in the ordinary course of business.

(f) Other commitments include minimum purchase commitments with certain trade vendors and contractual agreements to purchase goods or services in the ordinary course of business.

In addition to lease commitments and contractual obligations, our material cash requirements also include operating expenses such as payroll, store rent, and advertising expenses, which we expect to fund primarily with existing cash balances and cash flows from operations.

17 unchanged sentences

Revenue Recognition

At our America’s Best brand, our signature offer is two pairs of eyeglasses and a free eye exam for one low price.

At our America’s Best brand, our signature offer is an eye exam plus two pairs of eyeglasses for one great price.

Since an eye exam is a key component in the ability for acceptable prescription eyewear to be delivered to a customer, we concluded that the eye exam service, while capable of being distinct from the eyeglass product delivery, was not distinct in the context of the two-pair offer.

4 unchanged sentences

this amount would have been recognized at different times over the contract period.

Unearned revenue at the end of a reporting period is estimated based on processing and delivery times throughout the current month and generally ranges from approximately seven to ten days.

Unearned revenue at the end of a reporting period is estimated based on processing and delivery times throughout the current month and is generally within two weeks.

All unearned revenue at the end of a reporting period is recognized in the next fiscal period.

A one-day increase in our estimate of the average days needed to process delivery would have affected revenues in fiscal year 2024 b y approximately $4 million, which would ultimately have been recorded in the next fiscal year.

A one-day increase in our estimate of the average days needed to process delivery would have affected revenues in fiscal year 2025 by approximately $5 million, which would ultimately have been recorded in the next fiscal year.

The Company considers its revenue from managed care customers to include variable consideration and estimates such amounts associated with managed care customer revenues using the history of concessions provided and cash receipts from managed care providers;

5 unchanged sentences

We consider market-based indications of prevailing rental rates, lease incentives and discount rates for retail space when estimating the fair value of ROU assets.

Developing the estimates and assumptions used in our recovery and impairment evaluations require significant judgment.

We had $362.2 million of property and equipment, net, and ROU assets of $408.6 million as of December 28, 2024.

Developing the estimates and assumptions used in our recovery and impairment evaluations require judgment.

We had $344.6 million of property and equipment, net, and ROU assets of $394.9 million as of January 3, 2026.

Changes in estimates and assumptions used in our impairment testing of property and equipment could result in future impairment losses, which could be material.

3 unchanged sentences

Impairment of Goodwill and Intangible Assets

We calculate the fair value of our reporting units using the income approach based on discounted cash flows analysis whereby estimated after-tax cash flows are discounted using a weighted average cost of capital.

The cash flows used in the analysis are based on financial forecasts developed internally by management and require significant judgment.

We calculate the fair value of our reporting units using a combination of income and market approaches.

The income approach uses estimated after-tax cash flows discounted using a weighted average cost of capital.

The cash flows used in the analysis are based on financial forecasts developed internally by management and require judgment.

Significant unobservable inputs used in the fair value measurement of the reporting units include, but are not limited to, revenue growth rates, costs applicable to revenue, SG&A and discount rates.

These assumptions are sensitive to future changes in the business profitability, changes in our business strategy, customer concentration risk and external market conditions, among other factors.

The market approach estimates fair value using market‑based multiples for comparable companies and requires significant management judgment.

Changes to the comparable company set or selected market‑based inputs can materially affect the estimated fair value of our reporting units.

“Goodwill and Intangible Assets” for further detail on goodwill impairment.

As of December 28, 2024, we had $698.3 million of goodwill, $240.5 million of non-amortizing intangible assets, and $8.3 million of other intangible assets, net of accumulated amortization.

As of January 3, 2026, we had $700.6 million of goodwill, $240.5 million of non-amortizing intangible assets, and $7.6 million of other intangible assets, net of accumulated amortization.

Changes in estimates and assumptions used in our impairment testing could result in future impairment losses, which could be material.

Significant judgments and assumptions are required in our impairment evaluations.

Our America’s Best reporting unit was not at risk of failing the annual goodwill impairment test in fiscal year 2025.

A hypothetical 100 basis point increase in the discount rate used to estimate the fair value of the America’s Best reporting unit would not result in goodwill impairment in fiscal year 2025.

As part of the annual goodwill impairment test in fiscal year 2024, the carrying value of the Eyeglass World reporting unit was written down to its estimated fair value, resulting in a $19.2 million impairment charge in fiscal year 2024.

A hypothetical 100 basis point increase in the discount rate used to estimate the fair value of the Company’s Eyeglass World reporting unit would result in additional goodwill impairment of approximately $19 million.

Given the recent performance of the Eyeglass World brand, our impairment test reflected assumptions for future revenue growth and profitability that we believe to be achievable;

changes to the growth assumptions or future strategy for this brand may negatively affect the fair value of the associated goodwill asset.

Our Eyeglass World reporting unit was not at risk of failing the annual goodwill impairment test in fiscal year 2025.

A hypothetical 100 basis point increase in the discount rate used to estimate the fair value of the Company’s Eyeglass World reporting unit would not result in goodwill impairment in fiscal year 2025.

Future changes in a reporting unit’s business profitability, expected cash flows, changes in business strategy and external market conditions, among other factors, could require us to record an impairment charge for goodwill.

2 unchanged sentences

We record an impairment charge as the excess of carrying value over estimated fair value.

The fair value of the Eyeglass World trade name asset approximately equals its carrying value;

changes to the growth assumptions or future strategy for this brand may negatively affect the fair value of this asset.

A hypothetical 100 basis point increase in discount rates used to estimate the fair value of the Company’s trademarks and trade names would not result in an impairment of the America’s Best asset, but result in an approximate $5 million impairment of the Eyeglass World asset.

A 10 basis point decrease in the royalty rates used in the analyses would not result in an impairment of America’s Best asset, but result in an approximate $5 million impairment of the Eyeglass World asset in fiscal year 2024.

A 10 basis point decrease in the royalty rates used in the analyses would not result in an impairment of America’s Best or Eyeglass World’s assets.

If impairment indicators related to finite-lived, amortizing intangible assets are present, we estimate cash flows expected to be generated over the remaining useful lives of the related assets based on current projections.

If the projected net undiscounted cash flows are less than the carrying value of the related assets, we then measure impairment based on a discounted cash flow model and record an impairment charge as the excess of carrying value over the estimated fair value.

The carrying value of the Fred Meyer contract and relationship intangible asset was written down to its estimated fair value, resulting in a $10.5 million impairment charge in fiscal year 2024.

The Fred Meyer impairment testing was performed due to our decision to close certain Fred Meyer stores as part of our fleet review in fiscal year 2024.

Refer to Note 1.

3 unchanged sentences

Income tax accounting involves the use of estimates and complex judgments in a number of areas including the recognition of deferred tax assets and liabilities and the evaluation of uncertain tax positions.

Our net deferred liability balance as of December 28, 2024 was $77.9 million.

As future events, including tax law changes, are unpredictable, we continue to monitor developments in the tax landscape and adjust our assumptions and estimates

Our net deferred liability balance as of January 3, 2026 was $82.6 million.

As future events, including tax law changes, are unpredictable, we continue to monitor developments in the tax landscape and adjust our assumptions and estimates accordingly.

Changes in our assumptions and estimates could result in material changes to these balances.

1 unchanged sentence

Inventory shrinkage is estimated and recorded throughout the period in cost of sales based on historical results and current inventory levels.

Inventory values are adjusted for estimated obsolescence and written down to net realizable value (“NRV”) based on estimates of current and anticipated demand, customer preference, merchandise age, planned promotional activities, compliance with contact lens vendor return policies, and estimates of future retail sales prices.

Actual shrinkage is recorded throughout the year based upon periodic physical counts.

As of December 28, 2024, our total inventory balance was $93.9 million.

As of January 3, 2026, our total inventory balance was $89.3 million.

A 10% increase in the obsolescence and shrinkage reserves will not have a material impact on our financial position.

4 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 7. Management’s Discussion and Analysis